Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-Thalassemia
Customize your policy alerts
Sign up for Ambetter Nevada Policy CP.MP.108 alerts
Get alerted when Policy CP.MP.108 changes without checking for updates manually.
Monitor payer policy activity
Guidance on medical necessity and coverage considerations for hematopoietic cell (allogeneic) transplantation in members with sickle cell anemia or β-thalassemia; intended for providers and payers administering Ambetter Nevada benefits.
No material clinical or coverage changes in this revision.
Coverage Criteria
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.